12 Questions with Chris Venezia
As the CEO of ProofPilot, Chris Venezia has a track record of success with more than 18 years of strong leadership in product commercialisation, patient recruitment, marketing, and sales.
UK probes link between GLP-1 drugs and pancreatitis
The UK is studying cases of pancreatitis in people taking GLP-1 drugs for weight loss or type 2 diabetes to see if genetics may make them vulnerable.
First intranasal anaphylaxis drug launches in Germany
An alternative to epinephrine autoinjectors that can be delivered by a nasal spray has been launched in Germany, its first market, by ALK-Abello.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
7th TRP Europe | November 2025, Amsterdam | Agenda Released
With new targets like HER2 and FAP coming into focus, and promising data emerging beyond PSMA and SSTR2, real momentum is building in the field.
13th IMPACCT Real-World Evidence Summit
Recognized as the industry’s most established and trusted event for real-world evidence and evidence generation professionals
16th World ADC San Diego 2025
The World’s Largest, Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference
EVERSANA expands commercialisation portfolio with OS Therapi...
EVERSANA, a leading provider of global commercial services to the life sciences industry, has announced two strategic partnerships to support the US commercialisation of innovative therapies from O
The Pharmaceutical Marketing Society and the Chartered Insti...
The PM Society is delighted to announce a new partnership with the CIM to build capability and excellence in marketing in the pharmaceutical industry.